Head Diagnostics

Head Diagnostics offers AI-driven digital tools for cognitive and neurological assessment.

Head Diagnostics is a company in life science, medical device based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2018.

Profile

Head Diagnostics specializes in AI-driven digital solutions for the assessment and management of neurological diseases, focusing primarily on cognitive evaluation. The company offers HDx Cognition, a cloud-based neuropsychological assessment platform that digitizes established cognitive tests for efficient, standardized administration via tablet interfaces, providing immediate scoring and norm-based reporting. Additionally, the handheld device iTremor enables non-invasive measurement of ocular microtremor as an indicator of brainstem function. These clinically validated tools demonstrate reliability comparable to traditional methods, particularly in dementia and Alzheimer’s disease. Designed for ease of use and seamless integration into clinical workflows, Head Diagnostics’ solutions support scalable, ongoing monitoring, data sharing, and longitudinal care across various neurological conditions. The company contributes to innovation by leveraging AI to enhance diagnostic accuracy and efficiency in neurological health management.

The company sits in the life science, medical device segment, where it competes on its core product or service.

European Union (EU), Europe, Middle East, and Africa (EMEA) is where the company is located.

It is recorded at the Non_Equity_Assistance stage.

Its team size is recorded as c_00001_00010 employees.

Website: headdiagnostics.com